During the past decade, Krankenhaus Siloah - Medizinische Klinik II conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 8 clinical trials were completed, i.e. on average, 61.5% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 7 clinical trials were completed. i.e. 116.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Krankenhaus Siloah - Medizinische Klinik II" #1 sponsor was "University of Ulm" with 7 trials, followed by "Allergan" with 4 trials sponsored, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 4 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored and "German CLL Study Group" with 4 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Krankenhaus Siloah - Medizinische Klinik II" #1 collaborator was "Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)" with 2 trials as a collaborator, "Jazz Pharmaceuticals" with 2 trials as a collaborator, "Astellas Pharma Global Development, Inc." with 1 trials as a collaborator, "CRI-The Clinical Research Institute GmbH" with 1 trials as a collaborator and "EBMT Solid Tumors Working Party" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Krankenhaus Siloah - Medizinische Klinik II" are "Acute Myeloid Leukemia" (5 trials), "Lymphoma" (5 trials), "Acute Myeloid Leukemia (AML)" (4 trials), "Gastroparesis" (4 trials) and "Diabetes Mellitus" (3 trials). Many other conditions were trialed in "Krankenhaus Siloah - Medizinische Klinik II" in a lesser frequency.

Most popular intervention types in "Krankenhaus Siloah - Medizinische Klinik II" are "Drug" (28 trials), "Biological" (9 trials), "Radiation" (6 trials), "Procedure" (3 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (7 trials), "filgrastim" (6 trials), "radiation therapy" (6 trials), "Cytarabine" (5 trials) and "vincristine sulfate" (5 trials). Other intervention names were less common.

The vast majority of trials in "Krankenhaus Siloah - Medizinische Klinik II" are 33 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Krankenhaus Siloah - Medizinische Klinik II". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Krankenhaus Siloah - Medizinische Klinik II, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Krankenhaus Siloah - Medizinische Klinik II, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".